Yu Lu, VP Business Operations at STA Pharmaceutical, a WuXi AppTec company, explains how the company has established its technological platforms for the oligos and peptides market and where it sees the field developing in the future.
This interview was filmed as part of TIDES TV at TIDES US in San Diego, CA, May 20-23, 2019.
Join us at TIDES Europe, Amsterdam, 12-15 November 2019: https://bit.ly/2IoyYP2
More info on Creating technologies for the peptides and oligonucleotides field – STA Pharmaceutical
Creating technologies for the peptides and oligonucleotides field - STA Pharmaceutical - BingNews Search results
-
Current Trends in the Use of Liposomes for Tumor Targeting
Benzoporphyrin photosensitizer-encapsulated PEGylated liposomes, modified with a peptide (Ala-Pro-Arg-Pro ... to a high-frequency alternating magnetic field, which ruptured the liposomes and ...
-
The Promise of Nanomedicine for Ocular Disease
Therefore, pharmaceutical industries will support ... and inherited retinal dystrophies have demonstrated that new medical technologies can be rapidly and successfully translated into clinically ...
-
Health: General - WBOC-TV 16, Delmarvas News Leader, FOX 21
Voltage-gated sodium channels (Nav) are integral in almost all aspects of human physiology, including cardiac and muscle function and pain perception. In this webinar, peptide inhibitors derived ...
-
Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics
In this mass, normal and malignant cells create tumor microenvironment that ... Multiplexed imaging technologies open new directions in pathology. Spatially resolved proteomic, genomic, and ...
-
xMAP® Connect Virtual Conference
as well as learn about innovative research and clinical applications of xMAP Technology. The virtual conference was recorded during the 2019 San Diego and Amsterdam xMAP Connect events.
-
xMAP® Connect Virtual Conference
as well as learn about innovative research and clinical applications of xMAP Technology. The virtual conference was recorded during the 2019 San Diego and Amsterdam xMAP Connect events.
-
Chemical glycobiology: why now?
Similarly, consortia have provided technology platforms and focus to a burgeoning field. Now ... much more difficult to handle than oligonucleotides and peptides. Beyond this first level of ...
-
Recycling and Reclamation Services Specifications
Production Lots / Field Scale Companies may have commercial ... These materials are based on a unique composition or alloy system, use a novel processing technology, or have properties designed for ...